AI Market Mood: Stock Dashboard
TFX
Fundamental
Company: Teleflex Incorporated
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: USA
Exchange: NYSE
Index: -
P/E: 28.22
EPS (ttm): 4.25
Insider Own: 0.68%
Shs Outstand: 44.19M
Perf Week: 3.37%
Market Cap: 5.30B
Forward P/E: 7.85
EPS next Y: 15.28
Insider Trans: 1.86%
Shs Float: 43.89M
Perf Month: 7.92%
Enterprise Value: 7.02B
PEG: 4.59
EPS next Q: 3.40
Inst Own: 101.96%
Short Float: 2.01%
Perf Quarter: -7.29%
Income: 191.93M
P/S: 1.74
EPS this Y: 0.46%
Inst Trans: 4.45%
Short Ratio: 1.66
Perf Half Y: -28.41%
Sales: 3.04B
P/B: 1.25
EPS next Y Percentage: 8.53%
ROA: 2.59%
Short Interest: 0.88M
Perf YTD: -32.66%
Book/sh: 96.01
P/C: 19.74
EPS next 5Y: 6.15%
ROE: 4.36%
52W High: 249.90 -52.04%
Perf Year: -48.48%
Cash/sh: 6.07
P/FCF: 13.36
EPS past 3/5Y: -47.52% -31.49%
ROIC: 3.13%
52W Low: 108.90 10.06%
Perf 3Y: -52.79%
Dividend Est.: 1.35 (1.13%)
EV/EBITDA: 8.06
Sales past 3/5Y: 2.74% 3.26%
Gross Margin: 55.77%
Volatility W: 2.38%
Volatility M: 2.85%
Perf 5Y: -68.06%
Dividend TTM: 1.36 (1.13%)
EV/Sales: 2.31
EPS Y/Y TTM: -23.73%
Oper. Margin: 19.67%
ATR (14): 3.38
Perf 10Y: -10.83%
Dividend Ex-Date: Aug 15, 2025
Quick Ratio: 1.44
Sales Y/Y TTM: 1.11%
Profit Margin: 6.31%
RSI (14): 53.85
Recom: 2.75
Dividend Gr. 3/5Y: 0.00% 0.00%
Current Ratio: 2.41
EPS Q/Q: 63.61%
SMA20: 2.29%
Beta: 1.08
Target Price: 132.62
Payout: 91.92%
Debt/Eq: 0.47
Sales Q/Q: 4.16%
SMA50: 1.56%
Rel Volume: 1.00
Prev Close: 120.68
Employees: 14100
LT Debt/Eq: 0.45
Earnings: Jul 31 BMO
SMA200: -19.88%
Avg Volume: 530.78K
Price: 119.86
IPO: Apr 24, 1967
Option/Short: Yes / Yes
EPS/Sales Surpr.: 10.93% 1.21%
Trades:
Volume: 529,205
Change: -0.68%
Technical:
Latest News:
Wells Fargo Sticks to Its Hold Rating for Teleflex (TFX) | Markets Insider neutral
TFX TFX
Summary: Analysts from Wells Fargo, Needham, and JMP Securities recently provided ratings on Teleflex (TFX) with varying perspectives. Teleflex reported a quarterly revenue of $773.91 million, slightly higher than the previous year, but with a lower net profit. The company provides medical technology products focused on improving patient outcomes and safety.
Full article2024-05-03T18:12:46Z